Literature DB >> 6824002

Clonidine raises blood pressure in severe idiopathic orthostatic hypotension.

D Robertson, M R Goldberg, A S Hollister, D Wade, R M Robertson.   

Abstract

The hemodynamic effects of clonidine were studied in four patients with sever idiopathic orthostatic hypotension and one patient with baroreceptor dysfunction. No depressor response to clonidine was observed in any patient with idiopathic orthostatic hypotension at any dosage. Rather, two patients responded to 0.4 mg of oral clonidine with a 40 mm Hg increment in systolic blood pressure lasting several hours. Each has been receiving clonidine, 0.4 mg twice daily, for one year with greatly increased functional capacity. The other two patients with idiopathic orthostatic hypotension had an even greater pressor response to 0.8 mg of oral clonidine, but adverse effects prevented continued therapeutic use. In marked contrast, the patient with baroreceptor dysfunction had a profound depressor response to 0.2 mg of clonidine. In the treatment of idiopathic orthostatic hypotension, the major advantage of clonidine over other pressor agents is its longer duration of action. The major adverse effects of the drug in these patients are sedation, dry mouth, altered mentation, and excessive hypertension. The drug should not be given to patients with mild idiopathic orthostatic hypotension or selective baroreceptor dysfunction, since severe hypotension may result.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6824002     DOI: 10.1016/0002-9343(83)90607-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  26 in total

Review 1.  Dysautonomia: perioperative implications.

Authors:  Hossam I Mustafa; Joshua P Fessel; John Barwise; John R Shannon; Satish R Raj; André Diedrich; Italo Biaggioni; David Robertson
Journal:  Anesthesiology       Date:  2012-01       Impact factor: 7.892

Review 2.  Denervation of carotid baro- and chemoreceptors in humans.

Authors:  Henri J L M Timmers; Wouter Wieling; John M Karemaker; Jacques W M Lenders
Journal:  J Physiol       Date:  2003-10-03       Impact factor: 5.182

3.  Autonomic dysfunction: diagnosis guided by therapy.

Authors:  R M Robertson; I Biaggioni; R Mosqueda-Garcia; D Robertson
Journal:  Trans Am Clin Climatol Assoc       Date:  1992

Review 4.  Hypothesis: Fever control, a niche for alpha-2 agonists in the setting of septic shock and severe acute respiratory distress syndrome?

Authors:  F Petitjeans; S Leroy; C Pichot; A Geloen; M Ghignone; L Quintin
Journal:  Temperature (Austin)       Date:  2018-05-22

5.  Pharmacological evidence of alpha 1- and alpha 2-adrenergic supersensitivity in orthostatic hypotension due to spinal cord injury: a case report.

Authors:  J M Senard; A Arias; M Berlan; M A Tran; A Rascol; J L Montastruc
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 6.  Management of postural hypotension.

Authors:  M S Kochar
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

Review 7.  Management of Supine Hypertension Complicating Neurogenic Orthostatic Hypotension.

Authors:  Jacquie Baker; Kurt Kimpinski
Journal:  CNS Drugs       Date:  2017-08       Impact factor: 5.749

8.  Multiple system atrophy: using clinical pharmacology to reveal pathophysiology.

Authors:  Jens Jordan; Cyndya Shibao; Italo Biaggioni
Journal:  Clin Auton Res       Date:  2015-03-11       Impact factor: 4.435

9.  Use of alpha 2 adrenoreceptor agonists and antagonists in the functional assessment of the sympathetic nervous system.

Authors:  D Robertson; M R Goldberg; C S Tung; A S Hollister; R M Robertson
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

10.  The head and neck discomfort of autonomic failure: an unrecognized aetiology of headache.

Authors:  D Robertson; D W Kincaid; V Haile; R M Robertson
Journal:  Clin Auton Res       Date:  1994-06       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.